The human papillomavirus (HPV) E1∧ E4 protein is the most abundantly expressed viral protein in HPVinfected epithelia. It possesses diverse activities, including the ability to bind to the cytokeratin network and to DEAD-box proteins, and in some cases induces the collapse of the former. E1∧ E4 is also able to prevent the progression of cells into mitosis by arresting them in the G 2 phase of the cell cycle. In spite of these intriguing properties, the role of this protein in the life cycle of the virus is not clear. Here we report that after binding to and collapsing the cytokeratin network, the HPV type 16 E1 ∧ E4 protein binds to mitochondria. When cytokeratin is not present in the cell, E1∧ E4 appears associated with mitochondria soon after its synthesis. The leucine cluster within the N-terminal portion of the E1 ∧ E4 protein is pivotal in mediating this association. After the initial binding to mitochondria, the E1 ∧ E4 protein induces the detachment of mitochondria from microtubules, causing the organelles to form a single large cluster adjacent to the nucleus. This is followed by a severe reduction in the mitochondrial membrane potential and an induction of apoptosis. HPV DNA replication and virion production occur in terminally differentiating cells which are keratin-rich, rigid squamae that exfoliate after completion of the differentiation process. Perturbation of the cytokeratin network and the eventual induction of apoptotic properties are processes that could render these unyielding cells more fragile and ease the exit of newly synthesized HPVs for subsequent rounds of infection.Papillomaviruses infect the skin and mucosa of many different hosts, including humans (1). In order to multiply in these tissues, these viruses have evolved and adapted their life cycle to the biology of the epithelium. Human papillomaviruses (HPVs) gain entry into the epithelium via microlesions, which allow them to infect the epithelial basal cells. While the viral episomes remain at a low copy number in basal cells, cellular proliferation leads to the generation of a pool of cells that contain viral DNA. Amplification of the HPV genome and the production of infectious virions do not occur until the infected cells undergo terminal differentiation (11,19). The amplification of papillomavirus DNA usually begins when infected keratinocytes differentiate into spinous cells (17). This is followed by the production of viral capsid proteins and the assembly of infectious particles. In order to replicate in differentiating cells, the E6 and E7 proteins of HPV stimulate the production of proteins required for DNA synthesis. This causes the differentiating cells to enter S phase (24, 26). The E6 and E7 proteins are able to do this largely because they can inactivate the p53 (32) and pRb (15, 27) proteins, respectively. It is noteworthy that in spite of inactivating two major tumor suppressor functions in the cell, normal productive HPV infections do not cause uncontrolled cellular proliferation leading to tumorigenesis. At most, hyp...